A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief

Completed · Phase 4

Conditions studied: Photorefractive Keratectomy

In brief

The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.

Key facts

Study ID

NCT00330798

Run by

Alcon Research

People needed

40

Starts

2006-02-01

Expected to finish

2006-06-01

Last updated by the study team

2016-11-18

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 19 years or older with healthy ocular status and pre-operative refractive anisometropia of less than 2.000 diopters between eyes undergoing bilateral PRK surgery.
• Other protocol-defined inclusion criteria may apply.

You may not qualify if…

• Those desiring PRK in only one eye, those in need of additional topical eye medications, those with history of drug/alcohol abuse, women breastfeeding or pregnant.
• Other protocol-defined exclusion criteria may apply.

Where it is running

• Lackland Air Force Base — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.